Dapagliflozin (CAS 461432-26-8)

« Back to Anti-Diabetes API

Dapagliflozin

CAS No. 461432-26-8
达格列净
Dapagliflozin structure
Chemical structure
CAS No.461432-26-8
Synonyms—
CategoryAnti-Diabetes API / Anti-Diabetes
Assay / Purity99%
Molecular FormulaC21H25ClO6
Molecular Weight408.9
Melting Point—
Boiling Point—
Density—
Flash Point—
AppearanceOff-white to white solid powder

Application and positioning

Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor supplied as the free base. It is used in oral tablets for type 2 diabetes and also for heart failure and chronic kidney disease. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.

Quality and documentation

  • Batch-specific Certificate of Analysis issued by the manufacturing site
  • SDS/MSDS and specification sheet available on request
  • Residual solvents and elemental impurities statements discussed per project
  • For pharmaceutical manufacturing and R&D use only — not for direct administration

Packaging and handling

  • Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
  • Small quantities in sealed aluminium foil bags
  • Palletised for air and sea freight; store dry, ventilated and protected from light

Related products

Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.

Interested in this product?

Contact us for price, COA, MSDS and lead time — custom synthesis available.

Request a Quote

Reference: CAS 461432-26-8 · PubChem CID 9887712